Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 6 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

4Total
Not Applicable (4)

Trial Status

Recruiting6

Clinical Trials (6)

Showing 6 of 6 trials
NCT04888936Recruiting

Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies

NCT05361811Not ApplicableRecruiting

Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial

NCT04395495Recruiting

RASopathy Biorepository

NCT06355622Not ApplicableRecruiting

Prevalence and Characterization of Pain in RASopathies

NCT05761314Not ApplicableRecruiting

Solid Tumors in RASopathies

NCT06331117Not ApplicableRecruiting

Effect of RAS/MAPK Pathway Hyperactivation on Growth' and Bone' Profile of the RASopathies

Showing all 6 trials

Research Network

Activity Timeline